Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid-potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment-Reference-Cited by-同舟云学术

Tissue inhibitor of metalloproteinases from human bone marrow stromal cell line KM 102 has erythroid-potentiating activity, suggesting its possibly bifunctional role in the hematopoietic microenvironment

Published:1990-07-30 Issue:1 Volume:268 Page:125-128
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:

Author:

Hayakawa Taro,Yamashita Kyoko,Kishi Jun-ichi,Harigaya Kenichi

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/0014-5793(90)80989-V/fullpdf

Reference42 articles.

1. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity

2. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity

3. Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity.

4. K562 cells produce and respond to human erythroid-potentiating activity

5. Proliferation of Haemopoietic Stem Cells in Vitro

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential morphological characteristics of murine fetal liver hematopoietic microenvironment in Swiss Webster mice;Cell and Tissue Research;2011-05-04

2. Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting;Nature Reviews Drug Discovery;2009-12

3. The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis;Critical Reviews in Clinical Laboratory Sciences;2008-01

4. Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38α pathway;Leukemia;2007-02-15

5. The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells;Experimental Cell Research;2005-03